Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.
AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.
BRAINBox provides objective evidence of injury and prediction of patient recovery.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
CorneaSense is a medtech startup developing a non-invasive eye sensor to measure ocular hydration for early disease detection.
Commons Clinic is a multi-specialty clinic offering minimally-invasive surgical and conservative musculoskeletal care.
Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases.
Heranova is developing innovative diagnostics and treatments designed to improve women's health and address reproductive challenges
Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.
Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.
AccuPulse is developing novel pulsed electric field ablation (PFA) generator and catheters.
Yili Pharmaceutical is a pharmaceutical R&D company.
BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 20 different industry categories.
Among tracked funding rounds, Vaxcyte received $575.0M in a Post-IPO Debt round. BioVenture's total known invested capital is $2.1B.
BioVenture's average investment size is $23.9M across its portfolio of 279 companies.
Recent BioVenture portfolio additions include Estuary Biotherapeutics, Altay Therapeutics, Vaxcyte, AnaCardio, Tempo Therapeutics. These companies were founded in 2020 or later.